Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study121

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study46

Views

Views
December 20254
January 20263
February 20260
March 202611
April 20268
May 20267
June 202613
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Netherlands7
United Kingdom5
Finland2
Argentina1
Brazil1
Chile1
Colombia1
Germany1
Algeria1
 

Top cities views

Views
Groningen6
San Jose2
Helsinki2
Amsterdam1
Ashburn1
Bogotá1
Caerphilly1
Chattanooga1
Columbus1
Durban1